ANERIA - Trademark Details
Status: 605 - Abandoned - After Publication
Image for trademark with serial number 87155668
Serial Number
87155668
Word Mark
ANERIA
Status
605 - Abandoned - After Publication
Status Date
2020-06-03
Filing Date
2016-08-30
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-01-31
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
DE JONGE, KATHLEEN RUS
Statements
Goods and Services
Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body
Translation of Words in Mark
The wording "ANERIA" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2020-06-03
Primary Code
005
Correspondences
Name
Matthew O. Brady
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2016-09-02NEW APPLICATION ENTERED IN TRAM
2016-09-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-09-06TEAS VOLUNTARY AMENDMENT RECEIVED
2016-09-06TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
2016-12-08ASSIGNED TO EXAMINER
2016-12-09NON-FINAL ACTION WRITTEN
2016-12-09NON-FINAL ACTION E-MAILED
2016-12-09NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-12-12EXAMINERS AMENDMENT -WRITTEN
2016-12-12EXAMINERS AMENDMENT E-MAILED
2016-12-12NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-12-12EXAMINER'S AMENDMENT ENTERED
2016-12-12APPROVED FOR PUB - PRINCIPAL REGISTER
2017-01-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-01-31PUBLISHED FOR OPPOSITION
2017-01-31OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-03-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-08-16TEAS EXTENSION RECEIVED
2017-08-16EXTENSION 1 FILED
2017-08-16EXTENSION 1 GRANTED
2017-08-18NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-01-30TEAS EXTENSION RECEIVED
2018-01-30EXTENSION 2 FILED
2018-01-30EXTENSION 2 GRANTED
2018-02-01NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-09-07TEAS EXTENSION RECEIVED
2018-09-07EXTENSION 3 FILED
2018-09-07EXTENSION 3 GRANTED
2018-09-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-03-01TEAS EXTENSION RECEIVED
2019-03-01EXTENSION 4 FILED
2019-03-01EXTENSION 4 GRANTED
2019-03-05NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-09-20TEAS EXTENSION RECEIVED
2019-09-24CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-09-20EXTENSION 5 FILED
2019-09-24EXTENSION 5 GRANTED
2019-09-25NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-06-02TEAS EXPRESS ABANDONMENT RECEIVED
2020-06-03ABANDONMENT - AFTER PUBLICATION
2020-06-03ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION